Skip to content
MarketScale
‹ Back to IndustriesEngineering & Construction

Pulling Back the Curtain on Worthen’s R&D Process

When it comes to research and development, a chemist’s work is never done. And Ian Churcher, R&D Laboratory Manager for the foam fabricating division of Worthen Industries with 27 years at the company under his belt, isn’t expecting to stop innovating any time soon. “It’s never complete. I guess you might think, well, we’ll hit…

This story was produced through MarketScale. See how Engineering & Construction teams put it to work with Partner & Channel Enablement.

Share

When it comes to research and development, a chemist’s work is never done.

And Ian Churcher, R&D Laboratory Manager for the foam fabricating division of Worthen Industries with 27 years at the company under his belt, isn’t expecting to stop innovating any time soon.

“It’s never complete. I guess you might think, well, we’ll hit on the perfect formula, and we’ll all retire, but that’s never going to happen. I’m convinced of that,” he said. “There’s always something you can improve upon and, also, things you don’t count upon.”

One surprise is how many mattresses are manufactured, both as a whole but also in terms of the market shifting to so many more being purchased online and shipped in a small box where they’re unpacked upon arrival. That meant an adaptation for the techs in the foam fabricating division.

“What that means is the mattress is made, the pieces of foam are laminated with our adhesive, and then [it is] put in a box and can be shipped out the same day to the customer,” Churcher said. “That creates some challenges. The adhesive has to perform faster. We cannot have residual moisture. It has to dry faster. And it means putting less adhesive on. I think the adhesive is something that perhaps people don’t think about, and I believe that’s a good thing.”

Out of sight, out of mind is the desired result from a mattress adhesive, with customers hopefully getting a good night’s sleep rather than worrying about what’s holding (or not holding) their mattress together.

They can rest assured that Churcher and his team are still at work, innovating and making the finest foam fabrication and mattress adhesive products possible.

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Engineering & Construction: are you visible to AI?

Before they reach out, Engineering & Construction buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Engineering & Construction expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's Engineering & Construction expertise into the articles, video, and social content B2B marketing buyers in your industry are searching for. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Engineering & Construction Insights

What Challenges Are Manufacturers Facing Under Annex 1?

What Challenges Are Manufacturers Facing Under Annex 1?

Manufacturers are facing significant challenges under Annex 1, which regulates sterile production processes. Compliance with these regulations is critical for maintaining product safety and quality. Identifying potential risks and implementing effective control measures are key aspects for manufacturers to address.

  • 01Annex 1 presents challenges in maintaining sterile production processes for manufacturers.
  • 02Compliance with Annex 1 regulations is crucial for product safety and quality.
  • 03Manufacturers must identify risks and implement effective control measures.

Aug 3, 2026

What Are the Biggest Challenges Pharmaceutical Manufacturers Are Facing Today?

What Are the Biggest Challenges Pharmaceutical Manufacturers Are Facing Today?

Pharmaceutical manufacturers face significant challenges such as ensuring quality control, navigating regulatory requirements, and managing supply chain disruptions. These issues are intensified by the need for innovation and rapid response to market demands. Companies must balance these factors to remain competitive in the industry.

  • 01Quality control is a major challenge for pharmaceutical manufacturers.
  • 02Regulatory compliance is essential but can be complex and time-consuming.
  • 03Supply chain disruptions require strategic management and contingency planning.

Aug 3, 2026

U.S. warehouse construction jumps 18% as data-center supply chains drive industrial real estate recovery

U.S. warehouse construction jumps 18% as data-center supply chains drive industrial real estate recovery

Industrial real estate construction in the U.S. reached over 305 million square feet in the second quarter of 2026, an 18% increase from the previous year. The surge is largely driven by demand from data-center equipment suppliers. This trend highlights the growing influence of data centers on industrial real estate recovery.

  • 01U.S. industrial real estate construction increased by 18% year-over-year in Q2 2026.
  • 02Demand for new constructions is primarily driven by data-center equipment suppliers.
  • 03Over 305 million square feet of industrial space is under development.

Aug 1, 2026

Explore More Engineering & Construction Insights

Read more expert perspectives from across Engineering & Construction.

Browse Engineering & Construction Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Engineering & Construction and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512